Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
about
Diagnostic and management difficulties in a case of multiple intracranial juvenile xanthogranuloma.Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2-chlorodeoxyadenosine: case report and review of the literature.A Japanese infant with systemic juvenile xanthogranuloma mimicking severe microangiopathy.Severe systemic juvenile xanthogranuloma is an indication for systemic therapy.
P2860
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
@en
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
@nl
type
label
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
@en
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
@nl
prefLabel
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
@en
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
@nl
P2093
P356
P1476
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
@en
P2093
Anne Pagnier
Corinne Armari Alla
Dominique Plantaz
Flavie Arbion
Jean Donadieu
Jean François Emile
Laurence Eitenschenck
Marie-Christine Machet
Marion Yvert
Pascale Blouin
P304
P356
10.1002/PBC.22629
P577
2010-10-01T00:00:00Z